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Abstract
The past 20-years have seen the development and evaluation of many health status measures.
Unlike the high standards demanded of those who conduct and report clinical intervention trials,
the methodological rigor for studies examining the sensitivity to change of health status measures
are less demanding. It is likely that the absence of a criterion standard for change in health status
contributes to this shortcoming. To increase confidence in the results of these types of studies
investigators have often calculated multiple change coefficients for the same patient sample.
The purpose of this report is to identify the conflict that arises when multiple change coefficients
are applied to the same patient sample.
Three families of change coefficients based on different assumptions concerning the sample
composition are identified: (1) the sample is homogeneous with respect to change; (2) subgroups
of patients who truly change by different amounts exist; (3) individual patients, many of whom truly
change by different amounts exist. We present several analyses which illustrate a major conceptual
conflict: the signal (a measure's true ability to detect change) for some of these coefficients appears
in the noise term (measurement error) of the others.
We speculate that this dilemma occurs as a result of insufficient preparatory work such as pilot
studies to establish the likely change characteristic of the patient population of interest. Uncertainty
in the choice of change coefficient could be overcome by conducting pilot studies to ascertain the
likely change characteristic of the population of interest. Once the population's change
characteristic is identified, the choice of change coefficient should be clear.
Review
The past two decades have seen considerable interest in
the development and evaluation of health status outcome
measures [1-14]. Although the assessment of reliability
and cross-sectional validity is straightforward, the same
cannot be said about the evaluation of a measure's ability
to detect change. Investigators have often expressed uncer-
tainty in the choice of study design and analysis, and state-
ments such as the following are common: "Because there
is not yet agreement on the optimal design and analysis
strategies for a responsiveness study, the authors evalu-
ated the responsiveness of the FRI and RM-18 using two
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methods" [10]; "A variety of statistics have been used to
assess responsiveness and no single one is superior" [2];
and "The purpose of this study was to determine if differ-
ent indices of responsiveness provided similar rank order-
ings of scales in terms of responsiveness" [5]. It is likely
that the absence of a gold standard for change in health
status plays a prominent role in stimulating uncertainty in
the choice of analysis. The solution to the expressed
conundrum has often been the application of a "shotgun
analysis" where multiple change coefficients are applied
to a common dataset [2,4,5,9-14]. In this paper we pro-
vide a brief review of prominent study designs and change
coefficients, and illustrate the conflict in applying change
coefficients from different "families of analytic methods"
to the same data.
Methodological shortcomings
The methodological sophistication and standards for
reporting clinical intervention trials stand in sharp con-
trast to those evident for longitudinal validity studies of
sensitivity to change. Agencies funding clinical trials
demand a clearly stated research question, evidence –
often in the form of a pilot study – supporting the sample
size, and a statement justifying the analysis. Journal edi-
tors require equal clarity and rigor when manuscripts per-
taining to clinical trials are considered for publication. All
too frequently reports of sensitivity to change of various
health status measures appear to be "studies of opportu-
nity," rather than carefully planned investigations. Nota-
bly absent from many studies are a clear statement of
purpose, elaboration of design details including the
expected extent to which the sample's true change is likely
to be homogeneous or heterogeneous (we will subse-
quent refer to this as the sample's change characteristic),
justification of sample size, and a commitment to the
most appropriate analysis [2,5,6,9,11,14,15]. The impor-
tance of specifying the change characteristic of the sample
is that it dictates the choice of change coefficient, or at
least the family from which the change coefficient will be
selected.
Study designs and sample change characteristics
Previous monographs have provided comprehensive
reviews of popular designs for sensitivity to change studies
[16-18] and it is not our intent to repeat these discussions.
However, to set the stage we identify three popular
designs and their corresponding samples' change charac-
teristics: (1) patients who are expected to truly change by
approximately the same amount are assessed at two
points in time [1]; (2) two or more identifiable subgroups
of patients who are expected to change by different
amounts are assessed at two points in time [19]; and (3)
patients, many of whom, are expected to truly change by
different amounts are assessed at two points in time [20].
To distinguish between Designs 1 and 3 we will refer to
Design 1 as being homogeneous and Design 3 as being
heterogeneous with respect to change. Design 2 shares the
characteristics of Designs 1 and 3. Consistent with Design
1 is the assumption that patients within a subgroup truly
change by approximately the same amount and the extent
to which differences occur is attributed to measurement
error. Like Design 3, the ability of a measure to detect true
change is reflected by the extent to which the measure is
capable of differentiating the amount of change between
units that truly change by different amounts. The units are
groups of patients for Design 2 and individual patients for
Design 3.
Although the three study designs are conceptually simple,
ascertaining a sample's change characteristic is more
demanding. Perhaps the most popular method, particu-
larly for Designs 2 and 3, has been the retrospective global
rating of change [4,5,13,14,21]. Here, at the follow-up
assessment patients provide their impression of global
change in addition to completing the measure of interest.
This single item global rating of change is then used as the
standard for assessing the measure's ability to detect
change. Norman and colleagues [22] have challenged this
approach on three counts: (1) the notion that the meas-
urement properties of the single item global rating are
superior to the multi-item measure under investigation;
(2) judgments of change are psychologically difficult and
therefore suspect; and (3) correlated measurement error
between the global rating and the measure under investi-
gation inflates the true association between the two rat-
ings. With respect to the last point, Norman et al [22],
showed that the retrospective global rating of change can
result in declaring a measure responsive in a sample of sta-
ble patients.
An alternative to the retrospective rating is the prognostic
rating of change [19,23-25]. This approach is not subject
to errors of recall or correlated error; however, it is
dependent on the ability of the rater to accurately estimate
the extent of change that might occur. As the name sug-
gests, the essential feature of the prognostic rating method
is an a priori declaration of the sample's change character-
istic. Sensitivity to change studies have applied three
designs using prognostic ratings of change: (1) rand-
omized trials where interventions of known effectiveness
are compared to placebo or weaker interventions [19]; (2)
cohort studies where a known prognostic variable is used
to classify patients into groups that are expected to change
by different amounts [25]; and (3) clinicians assign
expected change scores to patients at their initial visit
[23,24]. Meenan et al [19], in a three group (placebo, oral
gold, injectable gold) randomized controlled trial, inves-
tigated the sensitivity to change of the Arthritis Impact
Measurement Scales and several other clinical measures.
Consistent with a priori hypotheses, the measuresHealth and Quality of Life Outcomes 2005, 3:23 http://www.hqlo.com/content/3/1/23
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demonstrated a gradient in treatment effects with the
injectable gold group demonstrating the greatest change
and the placebo group showing least change. Stratford
and Binkley [25] applied a cohort design where the natu-
ral history of patients with low-back pain was used to
established two groups of patients with different change
characteristics. Specifically, these investigators theorized
that patients with low-back pain of less than 2-weeks
duration would change more over the subsequent 2-week
interval than would patients who presented with low-
back pain of 2 or more weeks duration. Westaway et al
[23] investigated the sensitivity to change of the Neck Dis-
ability Index (NDI) [26] and Patient Specific Functional
Scale (PSFS) [27]. These investigators theorized that sea-
soned clinicians' would be able to distinguish among
patients who would change by different amounts over an
interval of several weeks. At the initial assessment clini-
cians rated patients' prognoses on a 5-point scale. Prog-
nostic ratings were based on clinical judgment alone. The
results demonstrated significant correlations between the
prognostic rating of change and the measures' change
scores.
Study designs and their respective families of analytic 
methods
Sensitivity to change studies are rich with descriptions of
change coefficients [2,5,6,9-12,15] which we place in the
following three groups or families according to study
design: Design 1, coefficients based on homogeneity of
patients change characteristics; (2) Design 2, between
group contrast coefficients; (3) Design 3, correlation
coefficients.
Homogeneous patient change
This design and analysis is based on the premise that the
sample consists of patients who are expected to change by
approximately the same amount over the study period. Of
interest is not what accounts for the change – it could be
the natural history or the application of an effective inter-
vention – but rather that the amount of change is expected
to be reasonably homogeneous among patients. The abil-
ity of a measure to assess change is quantified by dividing
the mean change (signal) by the variation in change or
sample characteristics at baseline (noise). The standard-
ized response mean (SRM = mean change/standard devi-
ation of change) [1] is a frequently reported change
coefficient associated with this design. Statistical tests
include the paired t-test and repeated measures ANOVA
with one within patient factor (occasion at 2 levels: base-
line and follow-up) and no between patient factor. Of the
three designs, this one is considered to be the weakest
because it does not challenge a measure's ability to dis-
criminate among different amounts of change [16,17].
Heterogeneous patient composition: between group 
contrast
This design is based on the premise that identifiable sub-
groups of patients who change by different amounts exist.
Change coefficients include area under receiver operating
characteristic (ROC) curves [18] and Norman's Srepeat [28].
Statistical analyses for this design include the z-statistic for
the area under a ROC curve [16], t-test for independent
sample means of change scores, and repeated measures
analysis of variance (ANOVA) with one within patient fac-
tor (occasion at 2 levels) and one grouping factor
(amount of change at 2 or more levels: small change, large
change) [28].
Heterogeneous patient composition: among patient 
contrast
Like the first design, this one investigates a single group of
patients. However, rather than the patients being reason-
ably homogeneous with respect to change, the patients
are expected to truly change by different amounts. Moreo-
ver, an essential aspect of this design is that an external
standard is applied, the change scores of which are com-
pared to the change scores of the measure of interest. A
measure's ability to detect change is based on a correlation
analysis [5,16,17].
Problem clarification
Investigators have often applied analyses and change coef-
ficients from the three families of tests to the same patient
sample [4,6,9,11], apparently without realizing that the
coefficients are based on different, and at times conflicting
assumptions concerning the sample's change characteris-
tic. For example, Kopec et al [4] reported a study that was
conceived to "determine whether the Quebec scale (a
functional status measure for patients with low-back
pain) is a reliable, valid, and responsive measure of disa-
bility, in back pain, and to compare it with other disability
scales." The sample was diverse in that it included patients
from physical therapy clinics, physiatry centers, rheuma-
tology clinics, family practice groups, and pain clinics. Sta-
tistical tests included the paired t-test, repeated measures
ANOVA with one grouping factor (amount of change),
and a correlation of the Quebec's change scores with those
of a retrospective global rating of change. Change coeffi-
cients included the SRM [1], Norman's Srepeat [28], and an
unnamed correlation coefficient. The three analyses were
applied to the same group of patients. To underscore the
theoretical conflict in applying these coefficients to the
same patient sample we will link the coefficients reported
by Kopec et al [4] through repeated measures and regres-
sion ANOVA tables.
Illustrative comparison of change coefficients
To facilitate discussion, we will make reference to the
dataset displayed in Table 1. These data represent theHealth and Quality of Life Outcomes 2005, 3:23 http://www.hqlo.com/content/3/1/23
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results from a hypothetical study where a health status
measure was administered to 20 patients at their baseline
assessment and at follow-up 2-months later. The investi-
gator believed that patients would improve over this inter-
val. Also, at the follow-up visit patients provided a global
rating of change on a 15-point scale (-7 to 7) [21]. Further-
more, the investigator dichotomized the patients' global
ratings using a cut-point of 5 on the global rating. The
investigator did not declare detailed a priori assumptions
concerning the extent to which patients were expected to
change by different amounts. Three analyses are pre-
sented: (1) a repeated measures ANOVA with no grouping
factor and 1-within patient factor; (2) a repeated measures
ANOVA with 1-grouping factor and 1-within patient fac-
tor; and (3) a correlation of the measure's change scores
with those of the retrospective global rating of change.
Although our illustration represents a hypothetical study,
the design and analyses are consistent with the approach
of Kopec et al [4] and many other studies reported in the
literature [6,9,12].
Homogeneous patient change analysis
The first analysis presented is a repeated measures ANOVA
with no grouping factor and 1-within patient factor, occa-
sion, at 2-levels (baseline and follow-up) [29]. The results
from this analysis are shown in Table 2. The statistical
analysis is equivalent to a paired t-test and the F-value of
33.49 is equal to the square of the paired t-value. The SRM
[1] is typically defined as:
Table 1: Summary of synthetic data
Patient ID Initial Assessment Follow-up Assessment Change Initial-follow-up Global Rating Global Rating Dichotomized
11 6 1 4 23 0
21 4 1 4 01 0
31 3 5 86 1
41 9 1 0 95 1
51 4 8 66 1
63 4 - 1 2 0
71 8 1 2 63 0
88 6 25 1
91 0 5 57 1
10 12 9 3 6 1
11 14 10 4 5 1
12 9 9 0 3 0
13 10 8 2 6 1
14 14 10 4 4 0
15 17 16 1 1 0
16 9 6 3 2 0
17 9 8 1 1 0
18 13 7 6 6 1
19 8 4 4 4 0
20 13 8 5 7 1
Mean 12.15 8.65 3.50 4.15
St. dev. 3.92 3.38 2.71 2.03
Table 2: Repeated measures ANOVA with one within patient factor and no grouping factor
Source DF SS MS F, (p)
Between Patients 19 439.60 23.14
Within Patients 20 192.00
Occasion 1 122.50 122.50 33.49, (<0.001)
Error 19 69.50 3.66Health and Quality of Life Outcomes 2005, 3:23 http://www.hqlo.com/content/3/1/23
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However, it can also be calculated from the repeated
measures ANOVA shown in Table 2:
where MSO is the mean square occasions, MSE is the
mean square error, and n is the number of patients.
Heterogeneous patient composition: between group 
analysis
This analysis is based on a repeated measures ANOVA
with 1-between patient grouping factor at 2-levels
(amount of change: a small amount or a large amount
according to the dichotomized retrospective global rating
of change) and the same within patient grouping factor as
in the previous analysis [29]. The results are reported in
Table 3. The group-by-occasion interaction term repre-
sents the extent to which the two groups changed by dif-
ferent amounts. The F-value for this term, F1,18 = 8.62, is
the square of the t-value that would have been obtained
had a t-test for independent sample means based on
change scores been applied. Norman's Srepeat  [28] is
calculated from the following information provided in
Table 3:
Heterogeneous patient composition: among patient 
analysis
This analysis represents a correlation of change scores
with patients' retrospective global ratings of change. To
show the location of the sources of variation, we gener-
ated the correlation coefficient from a regression analysis
Table 3: Repeated measures ANOVA with one within patient factor and one grouping factor
Source DF SS MS F, (p) Variance
Between Patients 19 439.60
Group 1 3.60 3.60
Error 18 436.00 24.22
Within Patients 20 192.00
Occasion 1 122.50 122.50 46.92, (<0.001)
Group by 
occasion
1 22.50 22.50 8.62, (0.009) 1.99
Error 18 47.00 2.61 2.61
Table 4: Regression analysis with group as a dummy variable
Source DF SS MS F, (p) Correlation
Regression 1 45.00 45.00 8.62, (0.009) r = 0.57
Residual 18 122.80 6.82
SRM
mean change (d)
standard deviation change (s )
SRM
3.50
2
d
=
=
. .71
SRM 1.29 =
SRM
2MSO
n
2MSE
SRM
2 (122.50)
20
2 (3.66)
SRM
3.50
2.71
SRM 1.29
=
=
=
=
Norman’s S = 
group by time variance
group by time vari
repeat a ance  +  error variance
Norman’s S = 
1.99
1.99  +  2.6
repeat 1 1
Norman’s S  = 0.43 repeatHealth and Quality of Life Outcomes 2005, 3:23 http://www.hqlo.com/content/3/1/23
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[30]. Also, we provide an intermediate analysis which rep-
licates the previous identifiable subgroup analysis. Here,
"group" was coded as a dummy variable (0 or 1): it is the
dichotomized rating of change shown in Table 1. Notice
that the F-value in Table 4 is identical to that for the
group-by-occasion interaction term reported in Table 3.
Table 5 presents the results from the correlation of change
scores with the raw retrospective global ratings of change.
Source of conflict among analyses
An examination of the sum of squares terms (SS) in the
ANOVA tables exposes the deficiency in applying these
tests to the same dataset. Notice that when a repeated
measures ANOVA with no grouping factor is applied, its
SS error term contains both the group-by-occasion inter-
action term and the residual error from the repeated meas-
ures ANOVA with a grouping factor. Thus, to the extent
that identifiable subgroups of patients exist, their presence
drives down the magnitude of the SRM: the signal has
become noise. The regression analyses reveal that this
phenomenon extends to situations where patients truly
differ in their change scores. Moreover, a comparison of
the two regression analyses and correlation coefficients
demonstrates that to the extent individual differences in
change scores truly exist among patients, a between group
analysis will under-estimate the ability of a measure to
detect change.
Reasons for "Agreement" among coefficients
A natural question is if the signal for the between group
and among patient change scores is contained in the noise
portion of the SRM, how is it possible to obtain a change
coefficient that differs from zero for this analysis? There
are at least three answers.
First, the reported coefficients may not truly differ from
zero. This statement is based on the observation that
change coefficients are often presented as point estimates
[2,4,5]. Without knowledge of a confidence interval or
hypothesis test, one cannot ascertain the chance that a
reported point estimate truly differs from zero. As a matter
of interest, the 95% confidence interval for the reported
SRM of 1.29 in our example is 0.91 to 1.92, confirming
that it is highly likely that it differs from zero.
The second explanation considers a situation similar to
that of our data where the SRM is greater than zero.
Although self-evident, it is important to acknowledge that
investigators interested in evaluating a measure's ability to
detect change select patients who, in most instances, are
expected to truly improve. Accordingly, the mean change
for the group will be greater than zero even when some
patients remain stable or get worse. When the mean
change is greater than zero, the SRM will be greater than
zero, even when subgroups or individual patients truly
change by different amounts.
The third explanation addresses the situation where
apparent patient differences in change scores, as repre-
sented by a correlation with another measure, are
observed in a sample that is truly homogeneous with
respect to change. In this case the design premise applied
most frequently by investigators is that change scores on
the measure under investigation will correlate with
patients' retrospective global ratings of change. To the
extent that in clinical practice clinicians ask patients about
their perceptions of change, this methodology seems rea-
sonable. However, the major limitation associated with
this approach is that it spuriously inflates the observed
correlation coefficient. To understand the mechanism of
this apparent association, a brief review of the relation-
ship and assumptions of observed, true, and error scores
is necessary [31]. In this example, the observed scores are
those reported by patients on the measure under investi-
gation and the retrospective global rating of change. True
scores are unknown values that represent the scores that
would be obtained in the absence of measurement error.
Error scores are the differences between observed scores
and true scores. The framework for comparing the change
scores of a measure to the global rating of change is that
of parallel assessments of the same attribute. A fundamen-
tal assumption is that the measure's error scores and the
global rating's error scores are uncorrelated [31]. How-
ever, it is extremely unlikely that the error scores are
independent when a patient provides both the measure's
change score and that of the global rating [22]. The conse-
quence is that the observed correlation will be greater than
zero even when the correlation between the true scores is
zero.
Table 5: Regression analysis with raw global rating change scores
Source DF SS MS F, (p) Correlation
Regression 1 56.30 56.30 12.25, (0.003) r = 0.64
Residual 18 139.00 4.60Health and Quality of Life Outcomes 2005, 3:23 http://www.hqlo.com/content/3/1/23
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Conclusion
The absence of a gold standard combined with multiple
change coefficients has created uncertainty for those who
investigate the sensitivity to change of health status meas-
ures. In an attempt to increase confidence in a measure's
ability to detect change investigators have often reported
multiple change coefficients derived from the same
patient sample, the belief being that uniform findings
among coefficients adds to the confidence in the results.
We contend that this approach is inconsistent with theory:
the signal for some coefficients is included in the noise of
others. We suggest that rather than calculating multiple
change coefficients, a more theoretically sound approach
is to devote more preparatory work to determine the likely
change characteristics of the patients of interest. Once the
sample's change characteristic is established, the choice of
change coefficient should be clear. Moreover, when the
opportunity presents, investigators are encouraged to
select the more rigorous designs which not only allow the
assessment of change, but also challenge a measure's abil-
ity to differentiate among patients or groups of patients
who change by different amounts.
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